Omnicell, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 1.13B | 1.30B | 1.15B | 1.11B | 1.18B | 6.5% | |
| Cost of Revenue | (577.37M) | (706.96M) | (647.18M) | (641.24M) | (676.80M) | 5.5% | |
Gross Profit | 554.65M | 588.99M | 499.93M | 471.00M | 508.04M | 7.9% | |
| Operating Expenses | |||||||
| Research & Development | (75.72M) | (104.97M) | (93.29M) | (90.41M) | (87.73M) | -3.0% | |
| Selling, General & Administrative | (389.43M) | (486.34M) | (425.97M) | (380.25M) | (408.64M) | 7.5% | |
| Depreciation & Amortization | (84.93M) | (99.17M) | (95.56M) | (89.75M) | (86.63M) | -3.5% | |
Operating Income (EBIT) | 89.51M | -2.32M | -19.33M | 337.00K | 11.66M | 3361.4% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | 14.76M | 24.90M | 11.90M | -52.2% | |
| Interest Expense | (22.39M) | (130.00K) | — | (4.53M) | (3.91M) | -13.6% | |
| Other Income/Expenses (Net) | -23.50M | -130.00K | -779.00K | 25.26M | -340.00K | -101.3% | |
Income Before Tax | 66.01M | -2.45M | -20.11M | 25.59M | 11.32M | -55.7% | |
| Income Tax Expense | (11.84M) | (8.10M) | (263.00K) | (13.06M) | (9.27M) | -29.0% | |
Net Income | 77.85M | 5.65M | -20.37M | 12.53M | 2.05M | -83.6% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $2 | $0 | $-0 | $0 | $0 | -83.5% | |
| Weighted Avg Shares Outstanding | 43.48M | 44.40M | 45.21M | 46.05M | 45.97M | -0.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 47.94M | 45.89M | 45.21M | 46.26M | 46.36M | 0.2% | |
EBITDA | 173.33M | 96.85M | 79.98M | 119.87M | 101.87M | -15.0% |
Explore OMCL
OMCL in the Healthcare
Small Cap